Skip to content

DocGo DCGO Restricted Cash

Restricted Cash at other companies

American Well logo
American WellAMWL
$795K0.0%
Nutex Health Inc. logo
Nutex Health Inc.NUTX
$3.29M
SRT
Strata Critical Medical, Inc. Class A Common StockSRTA
$264K-69.2%
CVS Health logo
CVS HealthCVS
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%
Net margin-62.2%
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCash.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's restricted cash?
DocGo (DCGO) reported restricted cash of $11.14M in Q1 2026.
How has DocGo's restricted cash changed year-over-year?
DocGo's restricted cash decreased by 53.7% year-over-year, from $24.05M to $11.14M.
What is the long-term trend for DocGo's restricted cash?
Over 5 years (2020 to 2025), DocGo's restricted cash has grown at a -61.6% compound annual growth rate (CAGR), from $175M to $1.47M.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.